Inventor · disambiguated record
Adam R. Mezo
Also filed as: MEZO ADAM · MEZO ADAM R · MEZO Adam Robert
24 granted patents·11 pending applications·1,034 citations·filing 2004–2024
97Inventor score
Files withBIOVERATIV THERAPEUTICS INC11SYNTONIX PHARMACEUTICALS INC6LILLY CO ELI5MEZO ADAM R4BRIGHAM & WOMENS HOSPITAL INC3
Top patents by PatentIndex Score
35 records- 0199US7381408B2Methods for chemically synthesizing immunoglobulin chimeric proteinsSYNTONIX PHARMACEUTICALS INC·Filed 2004·Granted Jun 3, 2008·173 cites·26 claims
- 0298US7862820B2Immunoglobulin chimeric monomer-dimer hybridsSYNTONIX PHARMACEUTICALS INC·Filed 2006·Granted Jan 4, 2011·120 cites·13 claims
- 0398US7404956B2Immunoglobulin chimeric monomer-dimer hybridsSYNTONIX PHARMACEUTICALS INC·Filed 2004·Granted Jul 29, 2008·301 cites·48 claims
- 0498US7348004B2Immunoglobulin chimeric monomer-dimer hybridsSYNTONIX PHARMACEUTICALS INC·Filed 2005·Granted Mar 25, 2008·218 cites·20 claims
- 0596US8329182B2Immunoglobulin chimeric monomer-dimer hybridsPETERS ROBERT T·Filed 2010·Granted Dec 11, 2012·82 cites·38 claims
- 0696US7820162B2Methods for chemically synthesizing immunoglobulin chimeric proteinsSYNTONIX PHARMACEUTICALS INC·Filed 2008·Granted Oct 26, 2010·26 cites·16 claims
- 0795US9636416B2Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2014·Granted May 2, 2017·20 cites·22 claims
- 0894US8932830B2Immunoglobulin chimeric monomer-dimer hybridsBIOGEN IDEC HEMOPHILIA INC·Filed 2012·Granted Jan 13, 2015·25 cites·27 claims
- 0990US9725496B1Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2017·Granted Aug 8, 2017·4 cites·27 claims
- 1090US8101186B2Peptides that block the binding of IgG to FcRnMEZO ADAM R·Filed 2007·Granted Jan 24, 2012·24 cites·33 claims
- 1189US8906844B2Immunomodulatory peptidesMEZO ADAM R·Filed 2008·Granted Dec 9, 2014·7 cites·20 claims
- 1287US11168125B2Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Nov 9, 2021·1 cites·10 claims
- 1384US10588935B2FC receptor (FcRn) binding peptides and uses thereofBRIGHAM & WOMENS HOSPITAL INC·Filed 2019·Granted Mar 17, 2020·2 cites·14 claims
- 1484US10400021B2Acylated insulin compoundLILLY CO ELI·Filed 2018·Granted Sep 3, 2019·3 cites·8 claims
- 1584US9938335B2Glucagon and GLP-1 co-agonist compoundsLILLY CO ELI·Filed 2016·Granted Apr 10, 2018·6 cites·21 claims
- 1684US2023023927A1Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1783US10046023B2FC receptor (FcRn) binding peptides and uses thereofBRIGHAM & WOMENS HOSPITAL INC·Filed 2016·Granted Aug 14, 2018·2 cites·11 claims
- 1882US9527890B2FC receptor (FcRn) binding peptides and uses thereofTHE BRIGHAM AND WOMENS'S HOSPITAL INC·Filed 2014·Granted Dec 27, 2016·5 cites·9 claims
- 1982US9012603B2Peptides that block the binding of IgG to FcRnMEZO ADAM R·Filed 2009·Granted Apr 21, 2015·6 cites·44 claims
- 2082US2022010000A1Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2181US10287564B2Procoagulant compoundsBIOVERATIV THERAPEUTICS INC·Filed 2013·Granted May 14, 2019·5 cites·11 claims
- 2273US2024398973A1Engineered antibody compounds and conjugates thereofLILLY CO ELI·Filed 2024·Application pending·0 cites
- 2370US11401322B2Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2017·Granted Aug 2, 2022·0 cites·25 claims
- 2470US9486507B2Pro-coagulant compounds and methods of use thereofTHORN KARINA·Filed 2012·Granted Nov 8, 2016·4 cites·21 claims
- 2568US2022135959A1Chimeric clotting factorsBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2667US2019183964A1FC RECEPTOR (FcRn) BINDING PEPTIDES AND USES THEREOFBRIGHAM & WOMENS HOSPITAL INC·Filed 2018·Application pending·0 cites
- 2766US11261437B2Procoagulant compoundsBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Mar 1, 2022·0 cites·12 claims
- 2866US10597436B2Acylated insulin compoundLILLY CO ELI·Filed 2019·Granted Mar 24, 2020·0 cites·1 claims
- 2965US11168316B2Chimeric clotting factorsBIOVERATIV THERAPEUTICS INC·Filed 2018·Granted Nov 9, 2021·0 cites·12 claims
- 3060US2011159540A1Methods for Chemically Synthesizing Immunoglobulin Chimeric ProteinsMEZO ADAM R·Filed 2010·Application pending·0 cites
- 3157US2022243189A1Procoagulant compoundsBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3256US2020155702A1Engineered Antibody Compounds and Conjuates ThereofLILLY CO ELI·Filed 2018·Application pending·0 cites
- 3352US2005281829A1Fc chimeric proteins with anti-HIV drugsHEHIR CRISTINA A T·Filed 2004·Application pending·0 cites
- 3449US2010048488A1Immunomodulatory peptidesSYNTONIX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 3547US2010310561A1Natriuretic fusion proteinsBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →